Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds works diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies: Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY), Buka Ventures Inc (OTCBB:NNRX), Softbank Corp. (Japan) (OTCMKTS:SFTBY), Arch Therapeutics Inc (OTCBB:ARTH).
Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) decreased -0.54% and closed at $69.60 on a traded volume of 556.569 shares, in comparison to 853.900 shares of average trading volume.
The company has a total market capitalization of $225.67 billion. Nestlé S.A., together with its subsidiaries, provides nutrition, health, and wellness products worldwide. The company offers baby foods primarily under the Cerelac, Gerber, Gerber Graduates, NaturNes, and Nestum brands
Will NSRGY Get Buyers Even After The Recent Rally? Find Out Here
Buka Ventures Inc (OTCBB:NNRX) plunged -67.13% and closed at $0.470 on a traded volume of 13.91 million shares, whereas its average trading volume is 524.010 shares. The Intra-day range for the stock is $0.46 and $1.48.
Will NNRX Get Buyers Even After The Recent Rally? Find Out Here
Softbank Corp. (Japan) (OTCMKTS:SFTBY) dropped -0.46% and closed at $34.85. The 52-week range for the stock is $14.56 and $35.02 and during the previous trading session the stock touched its highest price at $34.98. Its introductory price for the day was $34.52, with the overall traded volume of 732.160 shares. SoftBank Corp. operates in the information industry in Japan. It operates through four segments: Mobile Communications, Broadband Infrastructure, Fixed-line Telecommunications, and Internet Culture.
Will SFTBY Get Buyers Even After The Recent Rally? Find Out Here
Arch Therapeutics Inc (OTCBB:ARTH) after opening its trade at the price of $0.37, dropped -2.88% to close at $0.340 for the day. The stock moved on a traded volume of 1.24 million shares, in comparison to 338.844 shares of average trading volume. The 52-week range for the stock is $0.01 and $1.36 and during the previous trading session the stock touched its highest price at $0.40. Arch Therapeutics, Inc. operates as a life science company developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding.
Will ARTH Get Buyers Even After The Recent Rally? Find Out Here
About: Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock reader, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wall Street. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)